College of Medical Imaging, Shanxi Medical University, Taiyuan, China.
Department of Radiology, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
AJR Am J Roentgenol. 2020 Jul;215(1):142-147. doi: 10.2214/AJR.19.22125. Epub 2020 Apr 7.
The objective of our study was to develop a novel method to estimate single-kidney glomerular filtration rate (GFR) using a combination of contrast-enhanced CT and serum creatinine (SCr) values and to validate the resulting estimated glomerular filtration rates (eGFRs) by comparing them with the single-kidney Gates GFR, which is based on renal dynamic imaging. Sixty-two patients with asymmetric renal disease who underwent unenhanced and triphasic contrast-enhanced CT of the kidneys, Tc-diethylenetriamine pentaacetic acid renal dynamic imaging, and SCr testing within 1 week were retrospectively included. The eGFR was split into single-kidney GFRs of the left and right kidneys by a proportionality factor derived from the products of renal volume and CT number increments of the multiphasic CT images, which produced unenhanced phase (yielded by the renal volume proportional factor alone), arterial phase, venous phase, and nephrographic phase CT split eGFRs. The four CT split eGFRs were compared with the Gates GFR using the paired-sample test, Pearson correlation analysis, and Bland-Altman analysis. Correlation coefficients and 95% CIs between the four CT split eGFRs and Gates GFR were as follows: unenhanced phase, 0.729 (95% CI, 0.626-0.805); arterial phase, 0.781 (95% CI, 0.685-0.849); venous phase, 0.788 (95% CI, 0.690-0.839); and nephrographic phase, 0.842 (95% CI, 0.758-0.902) (all, < 0.001). The paired differences between the CT split eGFRs and Gates GFR were as follows: unenhanced phase, 2.04 ± 10.85 (95% CI, 0.01-4.07) mL/min/1.73 m; arterial phase, 2.04 ± 10.56 (95% CI, 0.06-4.02) mL/min/1.73 m; venous phase, 2.04 ± 10.04 (95% CI, 0.16-3.92) mL/min/1.73 m; and nephrographic phase, 2.04 ± 8.92 (95% CI, 0.37-3.71) mL/min/1.73 m. These results suggest a maximum deviation from the Gates GFR of ± 44.9% for the unenhanced phase eGFR, ± 43.7% for the arterial phase eGFR, ± 41.6% for the venous phase eGFR, and ± 36.9% for nephrographic phase eGFR. Split renal function can be estimated using a combination of contrast-enhanced CT and SCr values to calculate eGFR. The CT images of the nephrographic phase may be the optimal choice to use in this proposed method.
我们的研究目的是开发一种新的方法,通过结合使用对比增强 CT 和血清肌酐 (SCr) 值来估算单肾肾小球滤过率 (GFR),并通过将估算的肾小球滤过率 (eGFR) 与基于肾脏动态成像的单肾 Gates GFR 进行比较来验证这些结果。 我们回顾性纳入了 62 例患有单侧肾脏疾病的患者,这些患者在 1 周内接受了未增强和三相对比增强 CT 肾脏检查、Tc-二乙三胺五乙酸肾动态成像和 SCr 检测。eGFR 通过从多相 CT 图像的肾体积和 CT 数增量乘积中得出的比例因子来分割为左、右肾的单肾 GFR,生成未增强相(仅由肾体积比例因子生成)、动脉相、静脉相和肾实质相 CT 分割 eGFR。使用配对样本 t 检验、Pearson 相关分析和 Bland-Altman 分析比较 Gates GFR 与四种 CT 分割 eGFR。四种 CT 分割 eGFR 与 Gates GFR 的相关系数和 95%CI 如下:未增强相,0.729(95%CI,0.626-0.805);动脉相,0.781(95%CI,0.685-0.849);静脉相,0.788(95%CI,0.690-0.839);和肾实质相,0.842(95%CI,0.758-0.902)(均<0.001)。CT 分割 eGFR 与 Gates GFR 的配对差异如下:未增强相,2.04±10.85(95%CI,0.01-4.07)mL/min/1.73 m;动脉相,2.04±10.56(95%CI,0.06-4.02)mL/min/1.73 m;静脉相,2.04±10.04(95%CI,0.16-3.92)mL/min/1.73 m;和肾实质相,2.04±8.92(95%CI,0.37-3.71)mL/min/1.73 m。这些结果表明,未增强期 eGFR 的 Gates GFR 最大偏差为±44.9%,动脉期 eGFR 的 Gates GFR 最大偏差为±43.7%,静脉期 eGFR 的 Gates GFR 最大偏差为±41.6%,肾实质期 eGFR 的 Gates GFR 最大偏差为±36.9%。可以使用结合对比增强 CT 和 SCr 值来计算 eGFR 的方法来估算分肾功能。在该方法中,肾实质相的 CT 图像可能是最佳选择。